Home › Encyclopedia › Alexamorelin: Research Status and Compound Profile
Research / Unapproved

Alexamorelin: Research Status and Compound Profile

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC50H63N13O7
Molecular weight958.1 g/mol
Registered trials0
PubChem CID10011122

Key takeaways

  • Alexamorelin has no FDA-approved label and no dedicated clinical trial record.
  • It is classified as an unapproved research compound.
  • Its chemical identity is documented in public chemistry databases.
  • No human safety reporting data is currently available for review.

What alexamorelin is

Alexamorelin is a synthetic peptide with the molecular formula C50H63N13O7 and a molecular weight of approximately 958.1 g/mol. It is cataloged in PubChem under CID 10011122, which confirms its chemical structure but does not indicate any approved medical use. No FDA-approved drug label exists for this compound, and it has not been reviewed for safety or effectiveness in humans. Alexamorelin remains classified as an unapproved research substance.

Trial footprint

Public clinical trial registries show no registered studies for alexamorelin at this time. This absence of trial data means there is no clinical evidence available describing outcomes, safety, or effects in human subjects. Any information about this compound at present is limited to its chemical characterization rather than biological or clinical testing.

FAQ

Is alexamorelin FDA approved?
No, alexamorelin does not have an FDA-approved label. It is classified as an unapproved research compound with no approved medical use.
Are there any clinical trials studying alexamorelin?
Public registries currently show zero registered clinical trials for alexamorelin. This means there is no clinical trial evidence available regarding its effects in humans.
What is the chemical structure of alexamorelin?
Alexamorelin has the molecular formula C50H63N13O7 and a molecular weight of about 958.1 g/mol. It is listed in PubChem under CID 10011122 for reference.
Is there safety data available for alexamorelin?
No adverse event or side effect data has been reported for alexamorelin. Because it lacks clinical trials and an approved label, no safety profile currently exists.
What does 'unapproved research compound' mean for alexamorelin?
It means alexamorelin has not been evaluated or approved by regulatory authorities for any medical use. Its current status is limited to chemical identification rather than clinical application.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem

Updated 2026-08-04